We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Etanercept Kullanan Ankilozan Spondilitli Hastada Serviks Kanseri: Bir Olgu Sunumu.
- Authors
Doruk, Pınar; Adam, Mehmet; Leblebici, Berrin
- Abstract
Tumor necrosis factor-alpha inhibitors (anti TNF-alpha) are agents that increasingly used in the treatment of ankylosing spondylitis resistant to classical disease-modifying treatment and they provide better functional outcome. However, these agents have serious side effects. Their safety has been questioned by several published reports of increased risk for malignancies. In this study, we present a patient with ankylosing spondylitis who developed cervix cancer after receiving anti TNF-alpha therapy for 19 months.
- Subjects
CASE studies; CANCER patients; CERVICAL cancer; SPONDYLITIS; ETANERCEPT; TUMOR necrosis factors
- Publication
Journal of Physical Medicine & Rehabilitation Sciences, 2012, p162
- ISSN
1309-3843
- Publication type
Article
- DOI
10.4274/tftr.60024